financetom
Business
financetom
/
Business
/
Commerce Resources Agrees to Takeover By Australia-Listed Mont Royal Resources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerce Resources Agrees to Takeover By Australia-Listed Mont Royal Resources
Apr 11, 2025 4:44 AM

07:15 AM EDT, 04/11/2025 (MT Newswires) -- Commerce Resources ( CMRZF ) on Friday struck a merger agreement under which Australia-listed Mont Royal Resources will acquire all of Commerce's issued and outstanding common shares and combine their respective businesses.

The deal will create a Quebec-focused critical minerals explorer and developer by combining Commerce's Ashram Rare Earths and Fluorspar Project and Eldor Niobium exploration project and Mont Royal's Northern Lights Lithium Project.

The merger will result in a dual listing on the TSX Venture Exchange and the Australian Securities Exchange, enabling greater access to liquidity and funding for the Ashram project.

Under the agreement, Commerce shareholders will receive 2.3271 ordinary shares of Mont Royal for each Commerce share held. This represents an implied value of C$0.093 per Commerce share, an equity value for Commerce of C$17.2 million and an implied premium of 55% to Commerce's closing share price of C$0.06 on April 8.

Commerce shareholders will own about 85.3% of the outstanding Mont Royal shares and Mont Royal shareholders will own about 14.7%.

The deal is contingent upon Mont Royal raising up to A$10 million by issuing Mont Royal shares. Net proceeds will be used to advance the preliminary economic assessment at the Ashram project and to advance the Eldor project and the exploration pipeline at the Northern Lights project.

In addition, Commerce plans to conduct a convertible note financing with Commerce and Mont Royal shareholders and other investors to raise up to C$2.2 million, to be used as interim funding to continue studies for the development of the Ashram project and for working capital.

The combined company's board will be composed of a new non-executive chairman Cameron Henry, appointed by Commerce; two directors from Commerce, Jeremy Robinson and Adam Ritchie; and one non-executive director, expected to be Ronnie Beevor, appointed by Mont Royal.

A new CEO and president will be appointed prior to deal completion to replace interim Commerce CEO and President Jeremy Robinson.

The deal completion is subject to customary conditions for a transaction of this nature.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Video infrastructure provider Harmonic's Q3 revenue beats estimates, driven by SaaS growth
Video infrastructure provider Harmonic's Q3 revenue beats estimates, driven by SaaS growth
Nov 3, 2025
Overview * Harmonic Q3 2025 revenue of $142.4 mln beats analyst expectations * Adjusted EPS for Q3 2025 beats consensus, driven by SaaS growth in Video segment * Company repurchased 1.8 mln shares for $15.7 mln Outlook * Harmonic expects Q4 2025 revenue between $133 mln and $147 mln * Company anticipates Broadband revenue growth to increase in 2026 *...
EverQuote Q3 revenue beats expectations helped by strong showing in automotive insurance vertical 
EverQuote Q3 revenue beats expectations helped by strong showing in automotive insurance vertical 
Nov 3, 2025
Overview * EverQuote ( EVER ) Q3 revenue grows 20% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 beats analyst estimates, increasing 33% yr/yr * Company repurchased $21 mln of shares, indicating confidence in long-term growth Outlook * EverQuote forecasts Q4 2025 revenue between $174 mln and $180 mln * Company expects Q4 2025 variable marketing dollars of $46...
Nuvation Bio beats Q3 revenue expectations, driven by IBTROZI sales
Nuvation Bio beats Q3 revenue expectations, driven by IBTROZI sales
Nov 3, 2025
Overview * Nuvation Bio ( NUVB ) beat analysts' expectations for Q3 revenue, driven by IBTROZI sales * Company reported Q3 net loss of $55.8 mln * 204 patients started on IBTROZI in Q3, indicating strong launch progress Outlook * Company expects $25 mln milestone payment from Nippon Kayaku by year-end * Nuvation Bio ( NUVB ) plans sNDA to...
Compression therapy provider Tactile Systems' Q3 revenue beats estimates
Compression therapy provider Tactile Systems' Q3 revenue beats estimates
Nov 3, 2025
Overview * Tactile Systems ( TCMD ) Q3 revenue rises 17% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 beats analyst estimates, showing operational efficiency * Company authorizes $25 mln share repurchase program, indicating financial confidence Outlook * Company expects 2025 revenue between $317 mln and $321 mln, up from prior $310 mln to $315 mln * Company raises...
Copyright 2023-2026 - www.financetom.com All Rights Reserved